About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Legislative Tracking Tools
Monthly Archives: March 2010
Yes They Did! Now What? Opportunities in the Wake of Health Care Reform
Last night health care reform finally was passed by a vote of 219 to 212 and President Obama will sign it into law. An enormous amount of unnecessary drama was injected into the process, and that will take some time … Continue reading
Posted in Current Affairs Comments Off on Yes They Did! Now What? Opportunities in the Wake of Health Care Reform
Weekly Roundup – 3/19/10
Supposedly we are in the home stretch of health care reform, though one has a terrific sense of deja vu about that. Today Ramsay Baghdadi, Editor of the RPM report tweeted "My new "whip count": They have 224 "yes" votes … Continue reading
Posted in Uncategorized Comments Off on Weekly Roundup – 3/19/10
Twittering FDA – An Analysis of FDA’s Twittering Activity
The Food and Drug Administration has been dipping its toe into the proverbial social media waters. In this space, I've encouraged FDA to become more involved in Facebook as a means of pushing information out to consumers rather than waiting … Continue reading
Posted in Uncategorized Comments Off on Twittering FDA – An Analysis of FDA’s Twittering Activity